The Chief
Executive Officer of Novartis, Mr. Joseph Jimenez, has declared that they are
focusing on new technologies beyond therapeutic solutions, reports NaijaAgroNet.
“Novartis
is taking an outcomes approach, looking beyond therapeutic solutions to a focus
on new technologies, new commercial models, education and training,” says Jimenez.
He
made this declaration at the opening session of Novartis senior executives
assemblage in Basel, Switzerland for the first-ever tagged Novartis Africa Day 2013, to review the
company’s innovative work in Africa, including growing commercial activity,
novel approaches to expand access to high-quality, affordable medicines, local
talent development and the company’s Malaria Initiative.
“As
the continent increasingly grapples with the dual healthcare burden of
communicable and non-communicable diseases, we believe we can make a
significant difference in improving lives as the demand for healthcare rises,”
he said.
Africa,
he told NaijaAgroNet at the
opening session, faces immense challenges in its efforts to provide adequate
healthcare to its people. Stressing that the continent is home to one-seventh
of the world’s population, shoulders one-quarter of the global disease burden,
but it has only two per cent of the world’s doctors and less than one per cent
of global health expenditure.
“Life
expectancy is 15 years less than the global average. Africa is also at a
turning point as it begins to be challenged by a dual disease burden; both
communicable diseases that have historically plagued the continent, such as malaria,
and non-communicable diseases that are on the rise due to lifestyle changes,
such as diabetes,” he said.
Jimenez
also decried low levels of disease awareness, declining infrastructure and poor
distribution channels, which further compound Africa’s problems.
Novartis,
he said, employs a range of activities on the African continent with the aim of
becoming the leading healthcare company in Africa.
Programmes
to be discussed at the event include Sandoz Health Shops in Zambia, the Novartis
Malaria Initiative and SMS for Life.
NaijaAgroNet recalls that Sandoz
Health Shops have the potential to reach more than 2.5 million patients over
the next four years. While Novartis Malaria Initiative, reportedly provided
more than 600 million antimalarial treatments, without profit, to more than 60
malaria-endemic countries.
Additionally,
SMS for Life has reduced wait times and stock-outs for antimalarial medicines
from three months to a few days and from 79 per cent to less than 26 per cent
in three districts in Tanzania.
Isaac Oyimah/GEE/APO
... Linking agrobiz, people & technology
Incredible post I might want to thank you for the endeavors you have made recorded as a hard copy this fascinating and proficient article.
ReplyDeletegooey game
play friv
y 8 c om
Very good post! We are linking to this great article on our site. Keep up the good writing. I’m really enjoying the design and layout of your website. It’s a very easy on the eyes which makes it much more enjoyable for me to come here and visit more often. Did you hire out a developer to create your theme? Outstanding work!
ReplyDeleteio jogos 2019
2player best free online games
friv school Games to play